Bhalchandra V. Joshi

2.4k citations

46 papers · 2.0k indexed · 1 hit paper · h-index 23

Physiology top 0.1%
Molecular Biology top 10%
Neurology top 2%
Organic Chemistry top 5%
Immunology top 10%

Co-authors: Kenneth A. Jacobson Youichi Shinozaki Keiko Ohsawa Shinichi Kohsaka Zhan‐Guo Gao Schuichi Koizumi Kazuhide Inoue Makoto Tsuda
Topics: Adenosine and Purinergic Signaling (32 papers)Pharmacological Receptor Mechanisms and Effects (11 papers)Receptor Mechanisms and Signaling (8 papers)
Cited by: Physiology Neurology Endocrine and Autonomic Systems
Journals: Nature Circulation Research The FASEB Journal
Partner nations: United States United Kingdom South Korea

In The Last Decade

Bhalchandra V. Joshi

46 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis

2007 653 citations Schuichi Koizumi, Yukari Shigemoto‐Mogami et al. Nature profile →

Peers

Countries citing papers authored by Bhalchandra V. Joshi

Since Specialization

Citations

This map shows the geographic impact of Bhalchandra V. Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhalchandra V. Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhalchandra V. Joshi more than expected).

Fields of papers citing papers by Bhalchandra V. Joshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhalchandra V. Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhalchandra V. Joshi. The network helps show where Bhalchandra V. Joshi may publish in the future.

Co-authorship network of co-authors of Bhalchandra V. Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Bhalchandra V. Joshi. A scholar is included among the top collaborators of Bhalchandra V. Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhalchandra V. Joshi. Bhalchandra V. Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species 2009 ·Experimental Eye Research ·Zhao Wang,Chi Wai,Marcel Y. Ávila,K. Peterson–Yantorno,Richard A. Stone,Zhan-Guo Gao,Bhalchandra V. Joshi,Pedro Besada,Lak Shin Jeong,Kenneth A. Jacobson,Mortimer M. Civan	34
2	Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivatives 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Serge Van Calenbergh,Bhalchandra V. Joshi,Hyojin Ko,Rhonda L. Carter,T. Kendall Harden,Kenneth A. Jacobson	18
3	Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose 2009 ·Bioorganic & Medicinal Chemistry ·Hyojin Ko,Arijit Das,Rhonda L. Carter,Ingrid Fricks,Yixing Zhou,Andrei A. Ivanov,Artem Melman,Bhalchandra V. Joshi,Pavol Kováč,(unknown),Kenneth L. Kirk,T. Kendall Harden,Kenneth A. Jacobson	32
4	The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats 2008 ·Biochemical Pharmacology ·Avivit Ochaion,S. Bar‐Yehuda,Shira Cohen,Howard Amital,Kenneth A. Jacobson,Bhalchandra V. Joshi,Zhan‐Guo Gao,Faina Barer,R. Patoka,Luis Del Valle,(unknown),Pnina Fishman	60
5	Synthesis and pharmacological characterization of [125I]MRS1898, a high-affinity, selective radioligand for the rat A3 adenosine receptor 2008 ·Purinergic Signalling ·Zhan‐Guo Gao,(unknown),(unknown),Bhalchandra V. Joshi,Gary L. Griffiths,Kenneth A. Jacobson	10
6	Synthesis and structure–activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor 2007 ·Bioorganic & Medicinal Chemistry Letters ·Ga Eun Lee,Bhalchandra V. Joshi,(unknown),Lak Shin Jeong,Hyung Ryong Moon,Kenneth A. Jacobson,Yong‐Chul Kim	18
7	UDP acting at P2Y6 receptors is a mediator of microglial phagocytosisbreakdown → 2007 ·Nature ·Schuichi Koizumi,Yukari Shigemoto‐Mogami,(unknown),Youichi Shinozaki,Keiko Ohsawa,Makoto Tsuda,Bhalchandra V. Joshi,Kenneth A. Jacobson,Shinichi Kohsaka,Kazuhide Inoue	653
8	Agonists and Antagonists for P2 Receptors 2006 ·Novartis Foundation symposium ·Kenneth A. Jacobson,Stefano Costanzi,Bhalchandra V. Joshi,Pedro Besada,Dae Hong Shin,Hyojin Ko,Andrei A. Ivanov,Liaman Mamedova	44
9	P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure 2006 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jianbing Shen,Chunxia Cronin,Д. Л. Сонин,Bhalchandra V. Joshi,(unknown),David C. Harrison,Kenneth A. Jacobson,Bruce T. Liang	29
10	A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion 2006 ·Critical Care ·Idit Matot,Carolyn F. Weiniger,Evelyne Zeira,Eithan Galun,Bhalchandra V. Joshi,Kenneth A. Jacobson	50
11	Nucleoside Prodrugs of A3 Adenosine Receptor Agonists and Antagonists 2006 ·Collection of Czechoslovak Chemical Communications ·Pedro Besada,Liaman K. Mamedova,Krishnan K. Palaniappan,Zhan‐Guo Gao,Bhalchandra V. Joshi,Lak Shin Jeong,Mortimer M. Civan,Kenneth A. Jacobson	5
12	Action of Nucleosides and Nucleotides at 7 Transmembrane-Spanning Receptors 2006 ·Nucleosides Nucleotides & Nucleic Acids ·Kenneth A. Jacobson,Stefano Costanzi,Soo‐Kyung Kim,(unknown),Bhalchandra V. Joshi,Susanna Tchilibon,Heng T. Duong,Zhan‐Guo Gao	7
13	Purine Derivatives as Ligands for A3 Adenosine Receptors 2005 ·Current Topics in Medicinal Chemistry ·Bhalchandra V. Joshi,Kenneth A. Jacobson	18
14	Molecular Recognition at Adenine Nucleotide (P2) Receptors in Platelets 2005 ·Seminars in Thrombosis and Hemostasis ·Kenneth A. Jacobson,Liaman Mamedova,Bhalchandra V. Joshi,Pedro Besada,Stefano Costanzi	12
15	Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety 2005 ·Bioorganic & Medicinal Chemistry Letters ·Zhan‐Guo Gao,Bhalchandra V. Joshi,Athena M. Klutz,Soo‐Kyung Kim,Hyuk Woo Lee,Hea Ok Kim,Lak Shin Jeong,Kenneth A. Jacobson	30
16	Molecular Recognition at Purine and Pyrimidine Nucleotide (P2) Receptors 2004 ·Current Topics in Medicinal Chemistry ·Kenneth A. Jacobson,Stefano Costanzi,M. Ohno,Bhalchandra V. Joshi,Pedro Besada,Bin Xu,Susanna Tchilibon	46
17	Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors 2004 ·Biochemical Pharmacology ·Liaman K. Mamedova,Bhalchandra V. Joshi,Zhan‐Guo Gao,Ivar von Kügelgen,Kenneth A. Jacobson	135
18	Antiaggregatory activity in human platelets of potent antagonists of the P2Y1 receptor 2004 ·Biochemical Pharmacology ·Marco Cattaneo,Anna Lecchi,M. Ohno,Bhalchandra V. Joshi,Pedro Besada,Susanna Tchilibon,Rossana Lombardi,Norbert Bischofberger,T. Kendall Harden,Kenneth A. Jacobson	82
19	Chapter 13. A3 adenosine receptors 2003 ·PubMed ·Kenneth A. Jacobson,Susanna Tchilibon,Bhalchandra V. Joshi,Zhan‐Guo Gao	6
20	Ozonolysis of 6-N-benzoyl-9-(5-deoxy-2,3-O-isopropylidene-β-D-erythro-pent-4-enofuranosyl)adenine and related compounds 1993 ·Tetrahedron Letters ·Bhalchandra V. Joshi,Colin B. Reese	3

About Bhalchandra V. Joshi

Bhalchandra V. Joshi is a scholar working on Physiology, Virology and Organic Chemistry, having authored 46 papers that have together received 2.0k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (32 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Physiology (1.1k citations), Neurology (463 citations) and Endocrine and Autonomic Systems (106 citations). Bhalchandra V. Joshi has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Kenneth A. Jacobson, Youichi Shinozaki, Keiko Ohsawa, Shinichi Kohsaka, Zhan‐Guo Gao, Schuichi Koizumi, Kazuhide Inoue, Makoto Tsuda, Yukari Shigemoto‐Mogami and Susanna Tchilibon. Their work appears in journals such as Nature, Circulation Research and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact